Trials / Completed
CompletedNCT05041348
Metabonomic of Patients With Hepatitis B Cirrhosis Complicated With Sarcopenia.
Affiliated Hospital of Qingdao University
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- The Affiliated Hospital of Qingdao University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Sarcopenia is a common complication in liver cirrhosis patients and has been confirmed that associated with poor prognosis. China has the world's largest burden of hepatitis B virus-related liver cirrhosis (HBV-related liver cirrhosis). However, the relationship between HBV-related liver cirrhosis patients with muscle mass loss and normal muscle mass is remain largely unknown. Our study aimed to reveal the metabolic profile and identify potential biomarkers of muscle mass loss in HBV-related liver cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CT at the level of the third lumbar vertebra (L3) | Muscle mass loss was defined as an skeletal muscle mass index (SMI) less than 46.96 cm²/m² for males and less than 32.46 cm²/m² for females |
Timeline
- Start date
- 2021-08-17
- Primary completion
- 2022-07-15
- Completion
- 2022-08-17
- First posted
- 2021-09-13
- Last updated
- 2022-09-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05041348. Inclusion in this directory is not an endorsement.